Cargando…
Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
This study estimates health utilities (HU) in Sweden for a range of type 2 diabetes-related complications using EQ-5D and two alternative tariffs (UK and Swedish) from 1757 patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Ordinary least squares were used for statistic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053909/ https://www.ncbi.nlm.nih.gov/pubmed/24810579 http://dx.doi.org/10.3390/ijerph110504939 |
_version_ | 1782320465460592640 |
---|---|
author | Kiadaliri, Aliasghar A. Gerdtham, Ulf-G Eliasson, Björn Gudbjörnsdottir, Soffia Svensson, Ann-Marie Steen Carlsson, Katarina |
author_facet | Kiadaliri, Aliasghar A. Gerdtham, Ulf-G Eliasson, Björn Gudbjörnsdottir, Soffia Svensson, Ann-Marie Steen Carlsson, Katarina |
author_sort | Kiadaliri, Aliasghar A. |
collection | PubMed |
description | This study estimates health utilities (HU) in Sweden for a range of type 2 diabetes-related complications using EQ-5D and two alternative tariffs (UK and Swedish) from 1757 patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Ordinary least squares were used for statistical analysis. Lower HU was found for female gender, younger age at diagnosis, higher BMI, and history of complications. Microvascular and macrovascular complications had the most negative effect on HU among women and men, respectively. The greatest decline in HU was associated with kidney disorders (−0.114) using the UK tariff and stroke (−0.059) using the Swedish tariff. Multiple stroke and non-acute ischaemic heart disease had higher negative effect than a single event. With the UK tariff, each year elapsed since the last microvascular/macrovascular complication was associated with 0.013 and 0.007 units higher HU, respectively. We found important heterogeneities in effects of complications on HU in terms of gender, multiple event, and time. The Swedish tariff gave smaller estimates and so may result in less cost-effective interventions than the UK tariff. These results suggest that incorporating subgroup-specific HU in cost-utility analyses might provide more insight for informed decision-making. |
format | Online Article Text |
id | pubmed-4053909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-40539092014-06-12 Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden Kiadaliri, Aliasghar A. Gerdtham, Ulf-G Eliasson, Björn Gudbjörnsdottir, Soffia Svensson, Ann-Marie Steen Carlsson, Katarina Int J Environ Res Public Health Article This study estimates health utilities (HU) in Sweden for a range of type 2 diabetes-related complications using EQ-5D and two alternative tariffs (UK and Swedish) from 1757 patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Ordinary least squares were used for statistical analysis. Lower HU was found for female gender, younger age at diagnosis, higher BMI, and history of complications. Microvascular and macrovascular complications had the most negative effect on HU among women and men, respectively. The greatest decline in HU was associated with kidney disorders (−0.114) using the UK tariff and stroke (−0.059) using the Swedish tariff. Multiple stroke and non-acute ischaemic heart disease had higher negative effect than a single event. With the UK tariff, each year elapsed since the last microvascular/macrovascular complication was associated with 0.013 and 0.007 units higher HU, respectively. We found important heterogeneities in effects of complications on HU in terms of gender, multiple event, and time. The Swedish tariff gave smaller estimates and so may result in less cost-effective interventions than the UK tariff. These results suggest that incorporating subgroup-specific HU in cost-utility analyses might provide more insight for informed decision-making. MDPI 2014-05-07 2014-05 /pmc/articles/PMC4053909/ /pubmed/24810579 http://dx.doi.org/10.3390/ijerph110504939 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Kiadaliri, Aliasghar A. Gerdtham, Ulf-G Eliasson, Björn Gudbjörnsdottir, Soffia Svensson, Ann-Marie Steen Carlsson, Katarina Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden |
title | Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden |
title_full | Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden |
title_fullStr | Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden |
title_full_unstemmed | Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden |
title_short | Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden |
title_sort | health utilities of type 2 diabetes-related complications: a cross-sectional study in sweden |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053909/ https://www.ncbi.nlm.nih.gov/pubmed/24810579 http://dx.doi.org/10.3390/ijerph110504939 |
work_keys_str_mv | AT kiadalirialiasghara healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden AT gerdthamulfg healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden AT eliassonbjorn healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden AT gudbjornsdottirsoffia healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden AT svenssonannmarie healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden AT steencarlssonkatarina healthutilitiesoftype2diabetesrelatedcomplicationsacrosssectionalstudyinsweden |